Natco Pharma Limited — Others, 25-02-2026: News Verification
25-02-2026 | 10:02 am
25-02-2026 | 10:02 am
The Exchange has sought clarification from Natco Pharma Limited with respect to recent news item captioned Eris Lifesciences inks deal with Natco Pharma for weight-loss drug semaglutide.. The response from the Company is attached.
No comments yet. Be the first to comment!
